GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Open accessThe DOI matches its Crossref record; 213 of the 216 references it cites were found in a registry or an index.
Abstract
The intestine represents the body’s largest interface between internal organs and external environments except for its nutrient and fluid absorption functions. It has the ability to sense numerous endogenous and exogenous signals from both apical and basolateral surfaces and respond through endocrine and neuronal signaling to maintain metabolic homeostasis and energy expenditure. The intestine also harbours the largest population of microbes that interact with the host to maintain human health and diseases. Furthermore, the gut is known as the largest endocrine gland, secreting over 100 peptides and other molecules that act as signaling molecules to regulate human nutrition and physiology. Among these gut-derived hormones, glucagon-like peptide 1 (GLP-1) and -2 have received the most attention due to their critical role in intestinal function and food absorption as well as their application as key drug targets. In this review, we highlight the current state of the literature that has brought into light the importance of GLP-1 and GLP-2 in orchestrating intestine–microbiota–immune system crosstalk to maintain intestinal barrier integrity, inflammation, and metabolic homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, GLP-1 mitigates liver inflammation and fibrosis by inhibiting the NF-κB pathway, reducing the release of pro-inflammatory cytokines such as TNF-α and IL-6, and thus suppressing inflammatory pathways.307,413”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [307]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“3 million gut microbial genes that constitute the microbiome [81,82].”
BackgroundJaneway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947 · cited 3×
“The gut microbiota has been shown to function as an endocrine organ, producing and regulating numerous compounds that reach the circulation and act to influence the function of distal organs and systems, actively taking part in amino acid generation, pathogen displacement [148], as well as circadian rhythmicity, nutri…”
BackgroundInfluential
Cited by
Items 101–119 of 119
Boukind, A., Sharma, A. C., Henriquez, M. J., & Badran, S. M. (2026) · British journal of surgery · doi:10.1093/bjs/znag048
Liraglutide Modifies Gut Microbiota Without Modulating Doxorubicin-Induced Toxicity in Rats
Tonon, C. R., Monte, M. G., Balin, P. D. S., Fujimori, A. S. S., Ferreira, N. F., Vieira, N. M., Carreira, L. P., Rodrigues, M. A. M., Rodrigues, J., Junior, L. A., et al. (2026) · Antioxidants · doi:10.3390/antiox15050538
Saka, W. A., Oyedokun, P. A., Alade, T. A.-M., Oyeleke, B. T., Oyelaran, A. O., Oyedokun, M. D., Irozuoke, C. A., Olayemi, O. M., Oladepo, S., & Ndako, J. A. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02349-z
“…improvements in endothelial function and arterial stiffness (Moreira et al. 2018; Zhao et al. 2022; Shang et al. 2021; Gofron et al. 2025; Abdalqadir And Adeli 2022; Qi et al. 2025); however, current evidence remains predominantly preclinical, and microbiome-mediated effects are…”
Stein, R. A., Ganesh, A., Rianom, N. A., & Paratore, A. W. (2026) · Physiological Genomics · doi:10.1152/physiolgenomics.00230.2025
Liu, H., Li, W., Ni, C., Jing, S., Liu, J., & Zhao, Y. (2026) · Peptides · doi:10.1016/j.peptides.2026.171499
Oriquat, G., Abdulsahib, W. K., Mustafa, W. W., Gajjar, T. B., Hanumanthayya, M., Shukla, S. K., Panigrahi, R., Bainsal, N., & Khaitova, S. (2026) · PROTOPLASMA · doi:10.1007/s00709-026-02235-5 · Cited by 1
Ndlovu, N. (2026) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.53271
“SCFAs help regulate inflammation, improve gut barrier function, and stimulate the secretion of glucagon-like peptide-1 (GLP-1), a hormone involved in appetite regulation and glucose homeostasis (53,54).”
Besa, E. C., Kayamba, V., Mudenda, V. C., Mulenga, C., Musheba, E., Mubbunu, M., Frost, G. S., & Kelly, P. M. (2026) · Health Science Reports · doi:10.1002/hsr2.72772
Ohta, K., Kumei, H., Arai, N., Honda, S., Tominaga, Y., Ishikawa, M., Matsumoto, K., Kuwahara, T., Nakayama‐Imaohji, H., & Suzuki, S. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109597
Stephens, D. J., Johnson, E. B., & Johnson, B. J. (2026) · Recent Progress in Nutrition · doi:10.21926/rpn.2603018
Long-term outcomes in pediatric short bowel syndrome
Mutanen, A., Gunnar, R., Xavier, W., Duister, R. A. L., de Koning, B., & Tabbers, M. M. (2026) · Journal of Pediatric Surgery Open · doi:10.1016/j.yjpso.2026.100303
Şahan, A., Bayendur, S. H., Balıkçı, C., Tunç, A. C., & Acar, A. (2026) · Animals · doi:10.3390/ani16162607
“Secreted by enteroendocrine L cells, GLP-2 acts as an intestine-specific trophic factor that promotes enterocyte proliferation, inhibits apoptosis, and upregulates the resynthesis of disrupted tight junction proteins [11,12].”
Effects of GLP ‐1 agonists on the gut microbiota in type 2 diabetes mellitus: a systematic review
Dantas, R. S., Santos, L. V. S., de Oliveira, A. G. C., Barreto, M. D. S., Silva, D. M. R. R., Moura, P. H. M., Silva, E. E. D., Santos, R. S., Santana, L. A. D. M., Gopalsamy, R. G., et al. (2026) · FEBS Journal · doi:10.1111/febs.70656 · Cited by 3
“These drugs play a role in glucose homeostasis by stimulating insulin secretion, inhibiting glucagon, and reducing gastric emptying [9].”
Li, W., Shi, Q., Nie, Y., Wang, Z., Zheng, S., Tong, P., Gao, J., Wu, Y., & Chen, H. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112329
Building and regenerating intestines by manipulating intestinal stem cells
Kuo, C. J., Blutt, S. E., Donowitz, M., Estes, M. K., Guha, C., Klein, O. D., Li, L., Niland, J. C., Santos, A. J. M., Shivdasani, R. A., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01242-4 · Cited by 1
Foods as Modulators of GLP-1 Secretion
Ткаченко, Г. М., Kołodziejska, R., Rymuszka, A., Kamiński, P., & Kurhaluk, N. (2026) · Nutrients · doi:10.3390/nu18182995
Niyomugabo, A. P., Ntakirutimana, L., Izabayo, P., Isingizwe, C., Onaadepo, O., & Alagbonsi, A. I. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261492402 · Cited by 3
박수민, Lee, B., Kim, D., Sunirmal, S., Lee, M. G., Lee, H., Ock, S. A., & Yoo, J. G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0359086 · Cited by 1
“Considering that GLP-1 is crucial in promoting insulin secretion and maintaining intestinal barrier integrity, this downregulation implies simultaneous impairment of metabolic regulation and intestinal defense mechanisms under inflammatory conditions [90–94].”
Singh, S., Jindal, H., & Jha, H. C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44536-1.00019-5
Metadata
- Authors
- Abdalqadir, N., & Adeli, K.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Adeli, Khosrow
- ORCID
- Adeli, Khosrow
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2022-10-19
- Volume
- 10
- Issue
- 10
- Pages
- 2061
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC9610230
- OpenAlex
- W4306848286
- Cited by
- 119
- References
- 216
- Citations by year
- 2026: 36 · 2025: 38 · 2024: 36 · 2023: 8 · 2022: 1
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institute of Health Research (CIHR) (FDN-148396)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- glucagon-like peptide-1, glucagon-like peptide-2, intestinal barrier integrity, gut microbiota, intestinal immunity, gut-brain-microbiota axis, intestinal inflammation, metabolic homeostasis, gastrointestinal hormones, intestinal endocrine cells, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.